Reaction
Rhinocerebral Mucormycosis reporting signals
As of the last recalculation, Rhinocerebral Mucormycosis appears in 338 FAERS reports alongside 27 co-occurring drug terms. The strongest observed disproportionality signal is AMPHOTERICIN B (PRR 274.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Amphotericin B | 48 | 274.8 | 275.9 |
| Remdesivir | 39 | 203.6 | 204.2 |
| Posaconazole Delayed-Release | 22 | 131.9 | 132.1 |
| Micafungin Sodium | 17 | 130.0 | 130.2 |
| Meropenem | 52 | 117.7 | 117.9 |
| Posaconazole | 23 | 93.5 | 93.6 |
| Zinc | 30 | 82.1 | 82.2 |
| Zinc Chloride | 30 | 81.5 | 81.6 |
| Zinc Gluconate | 30 | 77.4 | 77.5 |
| Busulfan | 18 | 74.4 | 74.4 |
| Pegaspargase | 14 | 73.4 | 73.5 |
| Piperacillin Sodium,Tazobactam Sodium | 28 | 70.8 | 70.9 |
| Piperacillin And Tazobactam | 13 | 65.0 | 65.1 |
| Azithromycin | 36 | 61.5 | 61.6 |
| Azithromycin Monohydrate | 36 | 59.4 | 59.5 |
| Dexamethasone 1.5 Mg | 155 | 59.3 | 59.4 |
| Dexamethasone | 155 | 58.6 | 58.6 |
| Voriconazole Injection | 19 | 57.0 | 57.1 |
| Thiotepa | 8 | 52.8 | 52.9 |
| Vancomycin | 42 | 51.0 | 51.0 |
| Vancomycin Hydrochloride | 46 | 49.6 | 49.6 |
| Amikacin | 12 | 44.9 | 44.9 |
| Voriconazole | 19 | 40.8 | 40.8 |
| Fludarabine Phosphate | 22 | 36.8 | 36.8 |
| Timolol | 7 | 36.4 | 36.4 |
| Azacitidine For | 7 | 24.2 | 24.2 |
| Azacitidine | 10 | 21.4 | 21.4 |